CKD Patient at High Risk of Hyperkalaemia
Published: 03 March 2023
-
Views:
3225
-
Likes:
7
-
Views:
3225
-
Likes:
7
Overview
Watch this insightful case study presented by Prof James Burton where he presents a CKD patient at high risk of hyperkalaemia.
Watch Dr Shelley Zieroth's case study of an HF patient with moderate to severe hyperkalaemia.
These case studies, and their management strategies, will be discussed in a live roundtable discussion coming soon - register now to receive updates on the roundtable.
Watch these case studies today, answer the quick polls, and register to attend the broadcast to hear from the panel, who will also be offering practical solutions to challenges experienced in daily practice.
This programme is supported by an unrestricted educational grant from AstraZeneca.
More from this programme
Part 1
CKD Patient at High Risk of Hyperkalaemia
Prof James Burton presents a patient at high risk of Hyperkalaemia.
Faculty Biographies
James Burton
Professor of Renal Medicine
Prof James Burton is Honorary Consultant Nephrologist and Professor of Renal Medicine and Associate Dean for Clinical Research at the University of Leicester, Leicester, UK. His principal research interests are the mechanisms underlying uraemic cardiovascular disease modification of cardiovascular risk in patients with end-stage renal disease and the identification and application of novel biomarkers.
In addition Prof Burton is involved in the development and running of clinical trials; he is Chief Investigator for the NIHR funded NightLife trial investigating the impact of nocturnal dialysis on patient outcomes as well as the Kidney Research UK funded CONFIRM study exploring the utility of a novel cardiac magnetic resonance imaging (MRI) techniques in haemodialysis patients. Prof Burton is the independent Chair of two multi-centre NIHR Trial Steering Committees and sits on a number of others.
He is the current Chair of the UK Kidney Association Clinical…